Caption Management, LLC Viking Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.4 - $94.5 $6.88 Million - $37.4 Million
395,500 Added 182.26%
612,500 $50.2 Million
Q4 2023

Feb 14, 2024
BUY
$9.24 - $19.64 $831,600 - $1.77 Million
90,000 Added 70.87%
217,000 $4.04 Million
Q3 2023

Nov 14, 2023
BUY
$10.92 - $16.0 $860,496 - $1.26 Million
78,800 Added 163.49%
127,000 $1.41 Million
Q2 2023

Aug 14, 2023
BUY
$14.84 - $24.79 $715,288 - $1.19 Million
48,200 New
48,200 $781,000

Others Institutions Holding VKTX

# of Institutions
473
Shares Held
65.6M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email